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1. Introduction 
Epilepsy is a chronic disorder characterized by a spontaneous tendency for recurrent 
seizures which affects major aspects of a patient’s life, including cognitive, behavioral, 
psychological and social functioning (Foldwary & Wyllie, 1999). It has been reported that 
cumulative lifetime risks for epilepsy and for any unprovoked seizure are 3.1% and 4.1% 
respectively in industrialized countries. Estimates of annual incidence of epilepsy are 
reported as high as 43 cases per 100,000 of the population in so-called developed countries, 
and are almost double this figure in the developing world (McHugh & Delanty, 2008). 
Another estimation points out that there are 50 million people who have epilepsy in the 
world (WHO 2001,  Leonardi & Ustun, 2002). It was suggested that more than 80% of people 
with epilepsy live in developing countries, where the condition remains largely untreated 
(ILAE/IBE/WHO Annual Report, 1999; Meinardi et al., 2001).  
2. Quality of life and psychiatric aspects in epilepsy 
The science of health related quality of life (HRQOL) measurement rapidly evolved during 
the 1980s and 1990s within general health and in all medicine disciplines. (Tulsky & 
Rosenthal 2002). Despite a substantial increase in the number of published articles in recent 
years, research in the literature regarding the quality of lives of epileptic patients is 
relatively limited (Aydemir et al., 2004; Birbeck 2002). One of the most important reasons 
why HRQOL has become so important for those who engaged in epilepsy is related with 
well known characteristics of this disorder. Its chronic nature, presence of unexpected, 
intractable and/or frequent seizures, stigma and side effects of the antiepileptic drugs are 
some of these characteristics among others.   
Epileptic patients experience various problems due to this disorder which will result in a 
lower quality of life. Seizure frequency, side effects of the antiepileptic drugs, psychological 
comorbidity and stigma are the factors which are associated with the severity of the disease 
and these factors may cause an important impact on life quality of epileptic patients. 
Previous researches regarding quality of life (QOL) in epilepsy yielded contradictory results 
(Jacoby 1994; Leidy et al., 1999).  Although most reports in this field share a common message 
emphasizing the negative effects of epilepsy on patients’ HRQOL, there are still some other 
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studies which reported that this disease has little or no effect on epileptic patients’ QOL 
(Jacoby 1994; Leidy et al., 1999). Some authors suggested that the impact of epilepsy might be 
minimal if the disease is well controlled and HRQOL of patients in this condition would be 
nearly the same as those of healthy controls (Jacoby 1994; Leidy et al.,1999). On the other hand, 
epileptic patients living in Europe and North America were reported to have significant 
impairment in HRQOL(Stavem et al., 2000; Buck et al., 1999). This discrepancy in reported 
results may well be related to methodological issues and/or cultural differences. However, 
one can easily notice that especially in studies conducted with larger samples it was found that 
HRQOL is decreased in patients with epilepsy  (Baker et al., 2005; Baker et al., 1997). 
Baker et al. reported that epilepsy has the potential to negatively affect different aspects of 
what is called “quality of life” (Baker et al., 2005). The authors collected data from 3889 
patients with epilepsy from 10 different countries. In this multicenter survey it was 
concluded that the most commonly reported complaints interfering with daily living 
activities were nervousness, headaches and tiredness. Respondents in this study reported 
that their disease and its treatment had a significant impact on their HRQOL. Short Form-36 
(SF-36) was used in Baker et al.’s study and patients scored significantly lower in domains 
such as physical and social functioning, energy and vitality (Baker et al., 2005). 
In another multicenter (European) study again conducted by Baker et al. in 15 countries in 
Europe, data from more than 5000 patients were investigated and it was concluded that 
epilepsy had a negative effect on patients’ social and psychological well-being (Baker et al., 
1997). Argyriou et al. studied the impact of epilepsy on the psychological health and HRQOL 
of patients suffering from mild epilepsy in a rural area of southeastern Greece and reported 
that HRQOL of their patient sample was obviously affected while their psychological health 
remained nearly unaffected (Argyriou et al., 2004). Kutlu et al, investigated the HRQOL, 
anxiety and depression states of patients with epilepsy (PWE) (Kutlu et al., 2010). The SF-36 
health survey scores were significantly lower in all subscales in PWE compared with the 
control group. Total scores for Beck Depression Inventory (BDI) were significantly higher in 
epilepsy patients. Hamilton anxiety scale were also found to be significantly increased in the 
epilepsy group. It was concluded that epilepsy significantly interferes with QOL and 
psychologic health of patients. In the patient group relationship between the seizure frequency 
and vitality was found to be statistically significant (Kutlu et al., 2010). 
Women with epilepsy of childbearing age were reported to be at high risk of depression. 
Factors associated with depression include lack of occupation, the presence of an underlying 
disabling condition (with treatment), and the severity of epilepsy. Compared with the general 
population depressed women have greater impairment of HRQOL with epilepsy, which 
reflects the physical, social and emotional implications of the disease (Beghi et al., 2004). 
Several comorbid psychiatric problems accompany the clinical picture in epilepsy. According 
to Kanner depression is the most common comorbid psychiatric disorder in patients with 
epilepsy though it remains underrecognized and undertreated (Kanner, 2003). According to 
Devinsky, seizures by definition change behaviour (Devinsky, 2004). Behavioural disorders are 
perhaps the most common and serious complications in epilepsy. For patients with difficult to 
control epilepsy, depression makes a greater contribution to impaired quality of life than 
seizure frequency (Devinsky, 2004). In an extended review reported by Gaitatzias et al. it was 
pointed out that 6% of people with epilepsy in the general population appears to suffer from a 
psychiatric disorder while this rate increases to 10-20% in patients with temporal lobe and/or 
refractory epilepsy (Gaitatzis et al., 2004). In general 30% of PWE suffer from depression, 10-
20% from anxiety, 2-7% psychosis, 1-2% from personality disorders (Gaitatzis et al., 2004). On 
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the other hand, fear of seizures seems to play a very important role in psychiatric aspects of 
this disease. Newsom-Davis et al, stated that after an experience of a generalized epileptic 
seizure, a subsequent and anticipatory fear may well be seen in the sufferer (Newsom-Davis et 
al.,1998). Authors also underlined that there is a sufficient evidence in the literature suggesting 
that epileptic patients commonly fear death and or brain damage resulting from their seizures 
(Newsom-Davıs et al.,1998). Furthermore there is a strong association between the degree of 
psychopathology and the intensity of patients fears. 
To qualify as a specific phobia, the Diagnostic and Statistical Manual IV requires that the 
following criteria are met: (a) a marked and persistent fear is excessive or unreasonable and 
cued by the presence or anticipation of a specific object or situation; (b) exposure to the 
phobic stimulus provokes an immediate anxiety response; (c) the person recognizes that the 
fear is excessive or unreasonable; (d) the phobic situation is avoided or endured with intense 
anxiety or distress; and (e) avoidance, anxious anticipation, or distress in the feared situation 
interferes significantly with the person's normal routine, occupational functioning or social 
activities or relationships (Newsom-Davıs et al.,1998; DSM-IV, 1994). 
It is very well known that one of the most important features of epilepsy is stigma.  De Boer 
et al. reviewed the global burden and stigma of epilepsy (De Boer et al., 2008). The authors 
stated that people with disabilities are among the most vulnerable in any society. Hidden 
disabilities such as epilepsy leads to even a greater vulnerability. Epileptic people may fear 
going outside their homes unaccompanied and they also fear what people might think of 
them if they were to have a seizure in public. Inevitably this leads to social isolation and 
participation restriction in the community. 
In a recent study reported by Kanner et al. it was demonstrated that patients with 
subsyndromic depressive episodes (SSDEs), major depressive episodes (MDEs), anxiety 
disorders, and mixed MDEs (or SSDEs) with anxiety disorder(s) have a significantly worse 
quality of life than asymptomatic patients (Kanner et al., 2010). Authors also suggested that the 
comorbid occurrence of mixed MDE/anxiety disorders (particularly in the presence of more 
than one type of anxiety disorder) and SSDE/anxiety disorder yielded a worse impact on 
HRQOL than the occurrence of anxiety disorders alone. Another important finding of this 
study was that the comorbid occurrence of depressive and anxiety disorders have been found 
to have significant clinical implications beyond their impact on HRQOL which include: 
1. An increased suicidal risk.  
2. A worse course and poorer response to treatment of a depressive disorder  
3. An increased risk of MDE recurrence. types of anxiety increased the probability of a 
new depressive episode.  
4. An increased risk of failure to achieve a seizure-free state following an anterotemporal 
lobectomy in patients with pharmacoresistant temporal lobe epilepsy (Kanner et al., 
2010). 
Literature survey reveals enough evidence regarding the negative impact of mood disorders  
and anxiety symptoms on the quality of life of patients with epilepsy (PWEs) (Perrine et al., 
1995; Gilliam, 2002; Cramer et al., 2003; Boylan et al., 2004; Johnson et al., 2004; Loring et al., 
2004;  Tracy et al., 2007). Symptoms of depression and anxiety are independently associated 
with reduced HRQOL; psychiatric comorbidity explains more variance in HRQOL than the 
combined groups of clinical seizure or demographic variables (Johnson et al., 2004). A study 
with a large sample included 435 PWEs aiming to investigate the relative impact of mood 
and anxiety symptoms as well as social and seizure related variables on HRQOL (Tracy et 
al., 2007); the presence of depressive symptoms was the strongest predictor of the composite 
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and subscales of the Quality of Life in Epilepsy instrument used (QOLIE-31). In none of the 
cases did the severity of symptoms of depression interact significantly with the other 
variables, suggesting that its effect on HRQOL was direct and not mediated by other factors. 
In other studies conducted on patients with pharmacoresistant temporal lobe epilepsy 
(TLE), symptoms of depression were found to be the strongest independent predictors of 
poor quality of life but (unexpectedly) not the seizure frequency or severity (Perrine et al., 
1995; Gilliam, 2002; Boylan et al., 2004). All of the mentioned studies relied on screening 
instruments identifying symptoms of depression and anxiety, but did not generate 
psychiatric diagnoses of mood or anxiety disorders, based on predetermined diagnostic 
criteria, such as those suggested by the Diagnostic and Statistical Manual of Mental 
Disorders, Fourth Edition (DSM-IV-TR, 2000). The lack of a DSM-IV-TR diagnosis does not 
invalidate the significance of the data cited earlier. Studies on primary mood disorders 
emphasised the relatively high prevalence and significant clinical impact of subsyndromic 
forms of depressive disorders (Van Praag et al.,2004). Whether subsyndromic depressive 
episodes (SSDEs) differ from major depressive episodes (MDEs) or anxiety disorders in their 
impact on HRQOL of PWEs is yet to be established. The purpose of van Praag et al.’s  study 
was to test the following four hypotheses:  
1. Patients with SSDEs, MDEs, and anxiety disorders have worse HRQOL than 
asymptomatic patients, 
2. The more severe forms of depressive episodes (e.g., MDEs) have a greater negative 
impact on HRQOL measures than SSDEs, 
3. Depressive and anxiety disorders do not differ in their impact on HRQOL, 
4. Comorbidity of MDEs and anxiety disorders, but not of SSDEs and anxiety disorders, 
has a worse impact on HRQOL than MDEs and anxiety disorders alone (Van Praag et 
al.,2004). 
According to Winter, self-esteem is the most important part of the ego, which is also the 
most important factor contributing to psychosocial well-being (35). The most important 
determinants of self-esteem are (1) what we think of ourselves, as a reflection of what the 
people we care about think of us; (2) how we evaluate ourselves in comparison to other 
people; and (3) our ability to reach a positive outcome concerning issues that are important 
to us (Winter, 1996). Literature survey reveals contradictory data regarding the correlation 
between epilepsy and self-esteem (Winter, 1996; Reeve & Lincoln, 2002; Lee et al., 2008). 
Gauffin et al. studied self-esteem, and sense of coherence in a group of young adults wtih 
epilepsy and compared the results with those obtained five years earlier (Gauffin et al., 
2010). The authors found that there was a decline in both sense of coherence and self-esteem 
overtime in young adults with epilepsy. On the other hand Lee et al. reported that epilepsy 
in general has little impact on overall self-esteem in adolescents (Gauffin et al., 2010). 
As it was mentioned above several comorbid psychiatric problems such as depression, 
anxiety, psychosis and personality disorders accompany the clinical picture in epilepsy. One 
should also bear in mind the important role of antiepileptic drugs (AEDs) in 
psychopathology of epilepsy (Mula & Monaco, 2009). Mula and Monaco have drawn 
attention to the risk benefit ratio of AED usage in epilepsy. Possible adverse effects of AEDs 
include behavioural problems and psychiatric disorders. According to the authors it is often 
difficult to determine which pyshopathological manifestations are due to the drug therapy 
and which may be due to the characteristics of epilepsy disease itself. Mula and Monaco 
concluded that the most commonly reported psychiatric adverse effects of AEDs are non-
specific behavioral problems (Mula & Monaco, 2009). Among specific psychiatric diagnoses, 
depression is the most commonly reported. Psychosis is much less frequent. 
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In a study which investigated the sociodemographic and clinical factors associated with 
depression in epilepsy it was reported that, depressed subjects with epilepsy were 
significantly less likely to be married or employed and more likely to report comorbid 
medical problems and active seizures in the past 6 months (Thompson et al., 2009). Another 
important conclusion of this study was, when adjusted for all other variables, subjects with 
epilepsy reporting lamotrigine use were significantly less likely to be depressed compared 
to those not reporting lamotrigine use (Thompson et al., 2009). 
In a review covering 35 years of research specifically devoted to QOL in adult epilepsy, Leone 
et al. classified the questionnaires used in epilepsy according to validation, diffusion of use 
and spesificity of domains characteristics (Leone et al., 2005). The authors concluded that 
questionnaires covering all three aspects (Washington Psychosocial Seizure Inventory (WPSI), 
Epilepsy Surgery Inventory 55 Survey (ESI-55), Quality of Life in Epilepsy Inventory (QOLIE-
89), QOLIE-31, QOLIE-10, Liverpool Batteries) should be preferred when planning a QOL 
study in epilepsy. However those covering only two aspects (SF-36, The Side Effect and Life 
Satisfaction (SEALS) inventory, Epilepsy Psychosocial Effects Scale (EPSES), Performance, 
Sociodemographic aspects, Subjective evaluation/estimation questionnaire (PESOS), Quality 
of Life Assessment Schedule (QOLAS) could also be useful in selected situations or may 
become a first-choice instrument in the future, after more widespread use or complete 
validation (Leone et al., 2005).  On the other hand Wiebe et al. aimed to determine the 
minimum clinically important change, and small medium, and large changes in broadly used 
epilepsy specific and generic HRQOL instruments and found that QOLIE-89, QOLIE-31, SF-36, 
SF-36 physical composite score and HUI-III (health utility ındex mark III) differentiated 
between no change and minimum important change with precision (Wiebe et al., 2002). 
Birbeck et al. in their study evaluating ability of HRQOL measures to detect change overtime 
in people with epilepsy, suggested that SF-36 yielded responsiveness indices comparable to 
those of the epilepsy targeted (specific) measures (Birbeck et al., 2000). 
In a randomized controlled study May and Pfäfflin emphasized the efficacy of an educational 
treatment program for PWE. Modular service package epilepsy (MOSES) which was 
developed to improve patients’ knowledge and understanding about their epilepsy, its 
treatment and psychosocial consequences, was used in the study. The study clearly indicated 
the need for patient education. Even patients with a long history of epilepsy and with 
additional handicaps or diseases benefitted from the MOSES program (May & Pfäfflin 2002). 
Psychologically, persons with epilepsy may have feelings of worthlessness, fear, stigma, anger, 
and hopelessness, and may exhibit passive behavior (Chen et al., 2010). Stigmatization leads to 
discrimination, and people with epilepsy have been the target of prejudicial behavior in many 
aspects of life, over many centuries and in many cultures (De Boer et al., 2008; Pahl & De Boer, 
2005). These factors decrease their psychosocial function, self efficacy, and quality of life (Chen 
& Tsai , 2003; Pramuka et al., 2007) and even increase the suicide rate (Bell et al., 2009).  
Evidence shows that there is a spectrum of cognitive, behavioural and psychiatric disorders 
that accompany many forms of epilepsy. New discoveries may contribute to the 
development of therapies and management techniques that will better enable physicians to 
treat the full spectrum of disorders that epilepsy and tails (Berg , 2011). 
ILAE recently recommended that the term “benign” no longer be used to describe epilepsy, 
precisely because of the large number of disorders often seen in association with even 
relatively uncomplicated epilepsy (Berg et al., 2010). Berg suggested that any patient with 
epilepsy should be viewed as someone who is at risk of encountering a variety of 
consequences including cognitive problems, behavioural disorders, depression, suicide and 
also sudden death (Berg , 2011). 
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3. Conclusion 
Epilepsy, with its rich clinical features, is particularly important for HRQOL research. 
Despite a substantial increase in the number of published articles in recent years, research in 
the literature regarding the quality of lives of epileptic patients is relatively limited 
(Aydemir  et al., 2008; Birbeck et al., 2002). Most of the current reports in this field share a 
common message emphasizing the negative effects of epilepsy on patients’ HRQOL. 
Epileptic patients may experience various problems which will result in a lower quality of 
life. Seizure frequency, side effects of the antiepileptic drugs, psychological comorbidity and 
stigma are important factors associated with the severity of the disease and these factors 
may cause an important impact on life quality of epileptic patients. Stemming from a 
thorough review of the current literature, we can conclude that there is still a need for 
further scientific research with further validated instruments to find out more clear relation 
between epilepsy and HRQOL. 
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and stimulating work to offer food of thought to the readers from different disciplines. Around 5% of the total
world population have seizures but only 0.9% is diagnosed with epilepsy, so it is very important to understand
the differences between seizures and epilepsy, and also to identify the factors responsible for its etiology so as
to have more effective therapeutic regime. In this book we have twenty chapters ranging from causes and
underlying mechanisms to the treatment and side effects of epilepsy. This book contains a variety of chapters
which will stimulate the readers to think about the complex interplay of epigenetics and epilepsy.
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